Extracorporeal Elimination of Piperacillin/Tazobactam during Molecular Adsorbent Recirculating System Therapy

Heather A Personett1, Scott L Larson1, Erin N Frazee1,2,3

  • 1Pharmacy Services, Mayo Clinic Hospital, Rochester, Minnesota.

Pharmacotherapy
|August 21, 2015
PubMed

Insights

Molecular Adsorbent Recirculating System (MARS) therapy may enhance piperacillin/tazobactam clearance. Extended infusions maintained therapeutic piperacillin serum levels in patients undergoing MARS treatment.

Area of Science:

  • Pharmacology
  • Nephrology
  • Critical Care Medicine

Background:

  • The Molecular Adsorbent Recirculating System (MARS) is increasingly used for liver support, removing various molecules from the blood.
  • The impact of MARS on drug elimination, particularly antibiotics, is not well understood.
  • Suboptimal antibiotic levels can lead to poor patient outcomes in acute care settings.

Observation:

  • This study investigated piperacillin/tazobactam clearance in two patients undergoing MARS therapy.
  • Piperacillin concentrations were measured within the MARS circuit and in patient serum.
  • The study assessed the effectiveness of extended-infusion strategies for maintaining therapeutic drug levels.

Findings:

  • Piperacillin concentrations within the MARS circuit indicated enhanced drug elimination.
  • Extended-infusion piperacillin/tazobactam (3.375 or 4.5 g every 8 hours) successfully maintained desired serum concentrations.
  • Achieved piperacillin levels exceeded the minimum inhibitory concentrations for gram-negative infections.

Implications:

  • Successful dosing strategies for piperacillin/tazobactam in patients on MARS therapy were identified.
  • The study quantifies the influence of MARS components on piperacillin extraction.
  • Findings are crucial for acute care practitioners managing patients requiring antibiotics during liver support therapy.

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
903
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
354
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
338
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.8K
Drug Elimination: Non-Renal Routes01:23

Drug Elimination: Non-Renal Routes

The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
3.6K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.6K